Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Nathan J Dowden
4 May 2026
President & COO
Sold after exercise
15,000
$15.33
$229.95K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 1
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 396,101
History held since 1 Nov 2021